These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12017276)

  • 1. Combined effect of cisplatin and 5-fluorouracil with irradiation on tumor cells in vitro.
    Nagy B; Mucsi I; Molnár J; Thurzo L
    Anticancer Res; 2002; 22(1A):135-8. PubMed ID: 12017276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial wires releasing diffusing alpha emitters combined with chemotherapy improved local tumor control and survival in squamous cell carcinoma-bearing mice.
    Cooks T; Arazi L; Efrati M; Schmidt M; Marshak G; Kelson I; Keisari Y
    Cancer; 2009 Apr; 115(8):1791-801. PubMed ID: 19197995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined gamma-irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin.
    Caney C; Singh G; Lukka H; Rainbow AJ
    Int J Radiat Biol; 2004 Apr; 80(4):291-9. PubMed ID: 15204706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
    Budach W; Hehr T; Budach V; Belka C; Dietz K
    BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fundamental study of combination chemotherapy with THP, 5-FU and CDDP for human KB carcinoma cell line and its multidrug resistant cell line KB-C1--usefulness of treatment with 5-FU preceding CDDP].
    Kishimoto H; Manno Y; Tanaka H; Moridera K; Urade M
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):505-9. PubMed ID: 11329785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemo-immunotherapeutical studies on Dalton's lymphoma in mice using cisplatin and ascorbic acid: synergistic antitumor effect in vivo and in vitro.
    Sarna S; Bhola RK
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):327-33. PubMed ID: 8010874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
    Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T
    Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of interferon-beta in combination with 5-fluorouracil on the growth of esophageal cancer cells in vitro.
    Tsunoo H; Komura S; Ohishi N; Akiyama S; Kasai Y; Ito K; Nakao A; Yagi K
    Anticancer Res; 2001; 21(5):3301-6. PubMed ID: 11848487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combined treatment with cisplatin and 5-fluorouracil on cell growth and cell cycle kinetics of a mouse ascites tumor growing in vivo.
    Lewin F; Skog S; Tribukait B; Ringborg U
    In Vivo; 1990; 4(5):277-82. PubMed ID: 2133100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model.
    Straughn JM; Oliver PG; Zhou T; Wang W; Alvarez RD; Grizzle WE; Buchsbaum DJ
    Gynecol Oncol; 2006 Apr; 101(1):46-54. PubMed ID: 16271751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined antiproliferative activity of 5-fluorouracil and mitomycin-C against primary human ovarian tumors and cell lines in a clonogenic assay.
    Higashihara J; Berens ME; Collins LA; Homesley HD; Welander CE
    Gynecol Oncol; 1993 Feb; 48(2):171-9. PubMed ID: 8428687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemosensitizing effect of vitamin C in combination with 5-fluorouracil in vitro.
    Nagy B; Mucsi I; Molnar J; Varga A; Thurzo L
    In Vivo; 2003; 17(3):289-92. PubMed ID: 12929582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro demonstration of synergy between radionuclide and chemotherapy.
    Chenoufi N; Raoul JL; Lescoat G; Brissot P; Bourguet P
    J Nucl Med; 1998 May; 39(5):900-3. PubMed ID: 9591598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study of CF chemotherapy, combined with another one chemotherapeutic drug against head and neck cancer cell lines].
    Tsukuda M; Mochimatsu I; Kokatsu T; Ito K; Furukawa S; Inoue T; Watanabe S; Sawaki S
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):553-6. PubMed ID: 1373052
    [No Abstract]   [Full Text] [Related]  

  • 16. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
    Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
    Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of selenite combined with chemotherapeutic agents on the proliferation of human carcinoma cell lines.
    Schroeder CP; Goeldner EM; Schulze-Forster K; Eickhoff CA; Holtermann P; Heidecke H
    Biol Trace Elem Res; 2004; 99(1-3):17-25. PubMed ID: 15235138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.
    Nakajima TE; Ura T; Ito Y; Kato K; Minashi K; Nihei K; Hironaka S; Boku N; Kagami Y; Muro K
    Jpn J Clin Oncol; 2009 Jan; 39(1):37-42. PubMed ID: 19103671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoradiation using low-dose cisplatin and 5-fluorouracil in locally advanced squamous cell carcinoma of the skin: a report of two cases.
    Fujisawa Y; Umebayashi Y; Ichikawa E; Kawachi Y; Otsuka F
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S81-5. PubMed ID: 17052540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.